Catalyst Funds Management Pty »

Immuneering Corp - Class A shares owned by Catalyst Funds Management Pty

Quarter-by-quarter ownership of Immuneering Corp - Class A (IMRX) shares owned by Catalyst Funds Management Pty from 13F filings

Historical chart of Catalyst Funds Management Pty investment in Immuneering Corp - Class A

Tip: Access up to 7 years of quarterly data

All positions including Immuneering Corp - Class A held by Catalyst Funds Management Pty consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immuneering Corp - Class A by Catalyst Funds Management Pty

Quarter filed Position value Share count Share price at filing
2026-03-31 $68k 13k 5.27
2024-06-30 $7.2k 5.6k 1.28

More positions owned by Catalyst Funds Management Pty

Apple Ordinary Shares (AAPL)
Rio Tinto Adr (RIO)
Arm Holdings Adr (ARM)
Astrazeneca Ordinary Shares (AZN)
Medline Ordinary Shares (MDLN)
Cisco Systems Ordinary Shares (CSCO)
Abbvie Ordinary Shares (ABBV)
Teradyne Ordinary Shares (TER)
TechnipFMC Ordinary Shares (FTI)
Elbit Systems Ordinary Shares (ESLT)
Exxon Mobil Corp. Ordinary Shares (XOM)
Walmart Ordinary Shares (WMT)
Cheniere Energy Ordinary Shares (LNG)
Revolution Medicines Ordinary Shares (RVMD)
Valero Energy Corp. Ordinary Shares (VLO)

View all positions for Catalyst Funds Management Pty

Top funds holding Immuneering Corp - Class A

FMR
Sanofi
Vanguard Group
State Street Corporation
BlackRock
Millennium Management
Marshall Wace
Blue Owl Capital Holdings
Geode Capital Management
Occam Crest Management
Citadel Advisors
Connor, Clark & Lunn Investment Management
Summit Financial
UBS Group
Goldman Sachs Group

View all funds holding Immuneering Corp - Class A